Aquilo Capital Management as of March 31, 2025
Portfolio Holdings for Aquilo Capital Management
Aquilo Capital Management holds 13 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amgen Call Option (AMGN) | 33.5 | $19M | 60k | 311.55 | |
| Blueprint Medicines (BPMC) | 13.3 | $7.4M | 84k | 88.51 | |
| Arrowhead Pharmaceuticals (ARWR) | 12.6 | $7.0M | 550k | 12.74 | |
| Protagonist Therapeutics (PTGX) | 7.1 | $4.0M | 82k | 48.36 | |
| Kymera Therapeutics (KYMR) | 6.8 | $3.8M | 139k | 27.37 | |
| Precision Biosciences Com New (DTIL) | 6.2 | $3.5M | 726k | 4.77 | |
| Arvinas Ord (ARVN) | 4.5 | $2.5M | 361k | 7.02 | |
| Regenxbio Inc equity us cm (RGNX) | 3.5 | $1.9M | 271k | 7.15 | |
| Adicet Bio (ACET) | 3.3 | $1.9M | 2.5M | 0.76 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 2.6 | $1.5M | 172k | 8.49 | |
| Immatics SHS (IMTX) | 2.5 | $1.4M | 305k | 4.51 | |
| Repare Therapeutics Ord (RPTX) | 2.3 | $1.3M | 1.3M | 0.99 | |
| Zymeworks Del (ZYME) | 1.8 | $1.0M | 85k | 11.91 |
